Lewis Joseph's Form 4 filing
Tango Therapeutics, Inc. (TNGX) · filed Oct 6, 2022
- Accession no.
- 0000899243-22-033177
- Filed
- Oct 6, 2022, 9:15 PM ET
- Trade date
- Oct 4-6, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market purchases total $714.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lewis JosephCIK 0001015747 | 10% Owner |
| Boxer Asset Management Inc.CIK 0001465836 | 10% Owner |
| Boxer Capital, LLCCIK 0001465837 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 4, 2022 | Common Stock | PPurchaseAcquired | +25,606 | $3.67 | +$93,976.58 | 6,897,248 | Direct | |
| Oct 5, 2022 | Common Stock | PPurchaseAcquired | +45,500 | $3.93 | +$178,642.1 | 6,942,748 | Direct | |
| Oct 5, 2022 | Common Stock | PPurchaseAcquired | +40,500 | $3.84 | +$155,410.65 | 6,983,248 | Direct | |
| Oct 6, 2022 | Common Stock | PPurchaseAcquired | +70,394 | $4.06 | +$286,067.14 | 7,053,642 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.